{"id":2734,"date":"2026-11-20T19:21:10","date_gmt":"2026-11-20T19:21:10","guid":{"rendered":"https:\/\/chatscopeai.com\/news\/india-proposes-flexible-factory-rules-for-medicinal-gases-and-gelatin\/"},"modified":"2026-11-20T19:21:12","modified_gmt":"2026-11-20T19:21:12","slug":"india-proposes-flexible-factory-rules-for-medicinal-gases-and-gelatin","status":"publish","type":"post","link":"https:\/\/chatscopeai.com\/news\/india-proposes-flexible-factory-rules-for-medicinal-gases-and-gelatin\/","title":{"rendered":"India Proposes Flexible Factory Rules for Medicinal Gases and Gelatin Capsules"},"content":{"rendered":"\n<p class=\"wp-block-paragraph hsn-lede\">India&#8217;s Health Ministry proposed letting licensing officials relax factory rules for medicinal gases, gelatin capsules and disinfectants, with 30 days for comments.<\/p>\n<p class=\"wp-block-paragraph\"><strong>India&#8217;s Health Ministry has proposed letting drug licensing officials relax factory rules for medicinal gases, empty gelatin capsules and disinfectant fluids. The public has 30 days from the draft&#8217;s release to send objections before the government considers it.<\/strong><\/p>\n<p class=\"wp-block-paragraph\">The Ministry of Health and Family Welfare published the draft as Gazette Notification G.S.R. 985(E), dated 6 November 2026<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\" id=\"hsn-cite-1\">1<\/a><\/sup>. It would amend the Drugs Rules, 1945, so that exemptions these three product types had under the old Schedule M rules carry on under the revised version<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>. The draft rules will take effect on the date of their final publication in the Official Gazette<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\" id=\"hsn-cite-2\">2<\/a><\/sup>.<\/p>\n<div class=\"hsn-table\">\n<div class=\"pcrstb-wrap\"><table>\n<thead><tr><th>At a glance<\/th><th>Details<\/th><\/tr><\/thead>\n<tbody>\n<tr><td>What was published<\/td><td>Draft amendment to the Drugs Rules, 1945 (G.S.R. 985(E))<\/td><\/tr>\n<tr><td>Published on<\/td><td>6 November 2026 (notification date)<\/td><\/tr>\n<tr><td>Who can comment \/ Who must comply<\/td><td>Makers of medicinal gases, empty gelatin capsules and disinfectant fluids, and the public<\/td><\/tr>\n<tr><td>Feedback deadline \/ Effective date<\/td><td>30 days after copies of the gazette reach the public<\/td><\/tr>\n<tr><td>Final rules \/ Next milestone<\/td><td>Final publication in the Official Gazette, when the rules take effect<\/td><\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/div>\n<h2 class=\"wp-block-heading\">What is Schedule M, and why does it matter?<\/h2>\n<p class=\"wp-block-paragraph\">Schedule M is the part of India&#8217;s Drugs Rules that sets good manufacturing practice, the basic standards a medicine factory must meet. The government issued a revised Schedule M through G.S.R. 922(E), dated <strong>28 December 2023<\/strong><sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>. The revised rules set out requirements for factory space and equipment.<\/p>\n<p class=\"wp-block-paragraph\">Stakeholders then told the ministry that certain revised provisions did not fit some products<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>. The products were medicinal gases, empty gelatin capsules and disinfectant fluids. Their makers said the rules did not match how these goods are produced.<\/p>\n<h2 class=\"wp-block-heading\">What the expert board recommended<\/h2>\n<p class=\"wp-block-paragraph\">The Drugs Technical Advisory Board (DTAB), an expert panel on drug rules, discussed the issue at its <strong>93rd meeting on 16 February 2026<\/strong><sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>. The board found that some revised requirements may not be relevant to how these three product types are made<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>.<\/p>\n<figure class=\"hsn-fig hsn-fig--solid hsn-fig--v2\" data-at=\"what-the-expert-board-recommended\">\n  <div class=\"hsn-fig__axis\">\n    <h4>How the proposal developed<\/h4>\n    <div class=\"hsn-fig__ev\">\n      <span class=\"hsn-fig__evdate\">28 Dec 2023<\/span>\n      <span class=\"hsn-fig__evlab\">Revised Schedule M issued<\/span>\n    <\/div>\n    <div class=\"hsn-fig__ev\">\n      <span class=\"hsn-fig__evdate\">16 Feb 2026<\/span>\n      <span class=\"hsn-fig__evlab\">DTAB backs old exemptions<\/span>\n    <\/div>\n    <div class=\"hsn-fig__ev\">\n      <span class=\"hsn-fig__evdate\">6 Nov 2026<\/span>\n      <span class=\"hsn-fig__evlab\">Draft notification dated<\/span>\n    <\/div>\n    <div class=\"hsn-fig__ev\">\n      <span class=\"hsn-fig__evdate\">19 Nov 2026<\/span>\n      <span class=\"hsn-fig__evlab\">Ministry announces proposal<\/span>\n    <\/div>\n  <\/div>\n<\/figure>\n<p class=\"wp-block-paragraph\">It recommended keeping the exemptions these products had before Schedule M was revised<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>. The draft notification states that the government is acting after consulting the board<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>.<\/p>\n<h2 class=\"wp-block-heading\">What the draft rules change<\/h2>\n<p class=\"wp-block-paragraph\">The draft adds a short note at the end of Part XIII of Schedule M<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>. The note says the schedule does not set specific space and equipment requirements for medicinal gases, empty gelatin capsules and disinfectant fluids<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>.<\/p>\n<figure class=\"hsn-fig hsn-fig--solid hsn-fig--v2\" data-at=\"what-the-draft-rules-change\">\n  <div class=\"hsn-fig__table\">\n    <h4>The draft at a glance<\/h4>\n    <div class=\"pcrstb-wrap\"><table>\n      <thead>\n        <tr><th>Provision<\/th><th>What the draft says<\/th><\/tr>\n      <\/thead>\n      <tbody>\n        <tr><th>Products covered<\/th><td>Medicinal gases, empty gelatin capsules, disinfectant fluids<\/td><\/tr>\n        <tr><th>Who decides<\/th><td>Licensing Authority or Central Licence Approving Authority<\/td><\/tr>\n        <tr><th>Power granted<\/th><td>Relax or alter Schedule M requirements case by case<\/td><\/tr>\n        <tr><th>Takes effect<\/th><td>On final publication in the Official Gazette<\/td><\/tr>\n      <\/tbody>\n    <\/table><\/div>\n  <\/div>\n<\/figure>\n<p class=\"wp-block-paragraph\">Licensing officials gain the power to adjust the rules for these products case by case. The officials named are the Licensing Authority or the Central Licence Approving Authority, depending on the case<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>.<\/p>\n<div class=\"hsn-table\">\n<div class=\"pcrstb-wrap\"><table>\n<thead><tr><th>Area<\/th><th>What the draft provides<\/th><\/tr><\/thead>\n<tbody>\n<tr><td>Products covered<\/td><td>Medicinal gases, empty gelatin capsules, disinfectant fluids<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup><\/td><\/tr>\n<tr><td>Who decides<\/td><td>Licensing Authority or Central Licence Approving Authority<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup><\/td><\/tr>\n<tr><td>What they may do<\/td><td>Relax or alter Schedule M requirements in a particular case<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup><\/td><\/tr>\n<tr><td>Basis for a decision<\/td><td>Nature of the products and extent of manufacturing operations<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup><\/td><\/tr>\n<tr><td>Paper trail<\/td><td>Reasons must be recorded in writing<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup><\/td><\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/div>\n<h2 class=\"wp-block-heading\">How case-by-case approval would work<\/h2>\n<p class=\"wp-block-paragraph\">An official may relax or change a requirement only if the circumstances of a particular case make it necessary<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>. The official must <strong>record the reasons in writing<\/strong><sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>.<\/p>\n<figure class=\"hsn-fig hsn-fig--solid hsn-fig--v2 hsn-fig--cycle\" data-at=\"how-case-by-case-approval-would-work\">\n  <div class=\"hsn-fig__flow\">\n    <h4>From review to approval<\/h4>\n    <div class=\"hsn-fig__step\">\n      <strong>Official reviews the case<\/strong>\n      <span>Nature of products and operations<\/span>\n    <\/div>\n    <div class=\"hsn-fig__step\">\n      <strong>Reasons recorded in writing<\/strong>\n      <span>Needed to relax or alter rules<\/span>\n    <\/div>\n    <div class=\"hsn-fig__step\">\n      <strong>Manufacturer makes changes<\/strong>\n      <span>As the official directs<\/span>\n    <\/div>\n    <div class=\"hsn-fig__step\">\n      <strong>Manufacture approved<\/strong>\n      <span>After changes are made<\/span>\n    <\/div>\n  <\/div>\n<\/figure>\n<p class=\"wp-block-paragraph\">The official can then direct the manufacturer to make the needed changes. Once the changes are made, the official can approve manufacture of the product<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>. The ministry said the change lets licensing officials make product-specific decisions based on scientific and practical considerations<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>.<\/p>\n<h2 class=\"wp-block-heading\">Does this weaken quality standards?<\/h2>\n<p class=\"wp-block-paragraph\">The ministry said the proposal does not dilute quality, safety or regulatory oversight standards<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>. It described the change as a practical, product-specific approach that keeps manufacturers bound by the quality rules that apply to them<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>.<\/p>\n<p class=\"wp-block-paragraph\">The draft does not remove these products from Schedule M. It lets officials adjust space and equipment rules where they do not fit a product&#8217;s manufacturing process.<\/p>\n<h2 class=\"wp-block-heading\">How to send comments<\/h2>\n<p class=\"wp-block-paragraph\">The gazette issue carrying the draft is dated <strong>12 November 2026<\/strong><sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>. The government will consider the draft once <strong>30 days<\/strong> have passed from the date copies of that gazette are made available to the public<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>. It will consider objections and suggestions from any person received within that period<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>.<\/p>\n<p class=\"wp-block-paragraph\">Comments go to the Under Secretary (Drugs), Ministry of Health and Family Welfare, Kartavya Bhawan-1, New Delhi 110011<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup>. They can also be emailed to drugsdiv-mohfw@gov.in<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>.<\/p>\n<div class=\"hsn-table\">\n<div class=\"pcrstb-wrap\"><table>\n<thead><tr><th>Key date<\/th><th>What happens<\/th><\/tr><\/thead>\n<tbody>\n<tr><td>28 December 2023<\/td><td>Revised Schedule M issued (G.S.R. 922(E))<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup><\/td><\/tr>\n<tr><td>16 February 2026<\/td><td>DTAB recommends keeping the old exemptions<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup><\/td><\/tr>\n<tr><td>6 November 2026<\/td><td>Draft notification G.S.R. 985(E) dated<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup><\/td><\/tr>\n<tr><td>12 November 2026<\/td><td>Gazette issue carrying the draft<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup><\/td><\/tr>\n<tr><td>19 November 2026<\/td><td>Ministry announces the proposal<sup class=\"hsn-cite\"><a href=\"#hsn-ref-1\">1<\/a><\/sup><\/td><\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/div>\n<h2 class=\"wp-block-heading\">Key terms in plain words<\/h2>\n<div class=\"hsn-table\">\n<div class=\"pcrstb-wrap\"><table>\n<thead><tr><th>Term<\/th><th>Meaning<\/th><\/tr><\/thead>\n<tbody>\n<tr><td>Drugs Rules, 1945<\/td><td>India&#8217;s main rules for making, licensing and selling medicines<\/td><\/tr>\n<tr><td>Schedule M<\/td><td>The part of those rules setting factory standards for medicine makers<\/td><\/tr>\n<tr><td>Good manufacturing practice<\/td><td>Basic standards for clean, controlled and consistent drug production<\/td><\/tr>\n<tr><td>DTAB<\/td><td>Drugs Technical Advisory Board, the expert panel that advises the government on drug rules<\/td><\/tr>\n<tr><td>Licensing Authority<\/td><td>The official who grants and oversees drug manufacturing licences<\/td><\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/div>\n<p class=\"wp-block-paragraph\">The government will take up the draft once the 30-day comment period ends, and the rules take effect on final gazette publication<sup class=\"hsn-cite\"><a href=\"#hsn-ref-2\">2<\/a><\/sup>.<\/p>\n<h2 class=\"wp-block-heading hsn-refs-title\">Sources<\/h2>\n<ol class=\"hsn-refs\">\n<li id=\"hsn-ref-1\"><a class=\"hsn-refs__back\" href=\"#hsn-cite-1\" aria-label=\"Back to reference 1 in the text\">\u21a9<\/a> <a href=\"https:\/\/www.pib.gov.in\/PressReleasePage.aspx?PRID=2338313&amp;reg=3&amp;lang=1\" rel=\"noopener\" target=\"_blank\">Press Release Page | Press Information Bureau<\/a> <span class=\"hsn-refs__url\">https:\/\/www.pib.gov.in\/PressReleasePage.aspx?PRID=2338313&amp;reg=3&amp;lang=1<\/span><\/li>\n<li id=\"hsn-ref-2\"><a class=\"hsn-refs__back\" href=\"#hsn-cite-2\" aria-label=\"Back to reference 2 in the text\">\u21a9<\/a> <a href=\"https:\/\/egazette.gov.in\/WriteReadData\/2026\/278031.pdf\" rel=\"noopener\" target=\"_blank\">278031.pdf<\/a> <span class=\"hsn-refs__url\">https:\/\/egazette.gov.in\/WriteReadData\/2026\/278031.pdf<\/span><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>India&#8217;s Health Ministry proposed letting licensing officials relax factory rules for medicinal gases, gelatin capsules and disinfectants, with 30 days\u2026<\/p>\n","protected":false},"author":1,"featured_media":2732,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","_regnews_id":"36569","_hsn_citations":"[{\"n\":1,\"url\":\"https:\/\/www.pib.gov.in\/PressReleasePage.aspx?PRID=2338313&reg=3&lang=1\",\"label\":\"Press Release Page | Press Information Bureau\"},{\"n\":2,\"url\":\"https:\/\/egazette.gov.in\/WriteReadData\/2026\/278031.pdf\",\"label\":\"278031.pdf\"}]","_hsn_no_sources":"","_hsn_content_hash":"ea688acecc88c7df78496cc8b667640019e9b89e:987548d20b1bb163aa1f2571883e96fabbff9df7","_yoast_wpseo_focuskw":"drug manufacturing","footnotes":""},"categories":[51,40],"tags":[59],"class_list":["post-2734","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-asia","category-pharma-medical","tag-india"],"_links":{"self":[{"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/posts\/2734","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/comments?post=2734"}],"version-history":[{"count":1,"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/posts\/2734\/revisions"}],"predecessor-version":[{"id":2737,"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/posts\/2734\/revisions\/2737"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/media\/2732"}],"wp:attachment":[{"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/media?parent=2734"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/categories?post=2734"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chatscopeai.com\/news\/wp-json\/wp\/v2\/tags?post=2734"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}